Mustang Bio’s optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3% – Seeking Alpha
registrarjournal.com |
Mustang Bio’s optimized CAR–T therapy shows encouraging action in preclinical testing; shares ahead 3%
Seeking Alpha The study, conducted at the City of Hope National Medical Center, showed a greater antitumor effect for Mustang’s CD4+ CAR T cells compared to CD8+ CAR T cells. A Phase 1 trial in glioblastoma, the most aggressive type of brain tumor, is ongoing. Mustang Bio (NASDAQ:MBIO) Lifted to “Buy” at Zacks Investment ResearchStockNewsTimes |
Harvard Gazette |
Pig organs for human patients: A challenge fit for CRISPR
Harvard Gazette Over the past few years, researchers led by George Church have made important strides toward engineering the genomes of pigs to make their cells compatible with the human body. So many think that it’s possible that, with the help of CRISPR technology, … |
Bloomberg |
Pharma’s Biggest Dealmakers Face More Than M&A Risks
Bloomberg The age of gene therapies – medicines that work by altering human genes – is arriving, and with it, the potential for curing diseases with one-and-done treatments. But parts of the pharma world, including some of this year’s biggest dealmakers, are … |
Immuno-Oncology News |
1st Patient Treated in Phase 1 Trial of FS118, Potential Immunotherapy for Advanced Cancers
Immuno-Oncology News A Phase 1 trial testing FS118 – F-star’s antibody designed to target two immune checkpoint proteins – in solid and advanced cancers has dosed a first patient, the company announced. The U.S.-based study (NCT03440437) is expected to enroll 51 patients … |
Immuno-Oncology News |
1st Patient Treated in Phase 1 Trial of FS118, Potential Immunotherapy for Advanced Cancers
Immuno-Oncology News A Phase 1 trial testing FS118 – F-star’s antibody designed to target two immune checkpoint proteins – in solid and advanced cancers has dosed a first patient, the company announced. The U.S.-based study (NCT03440437) is expected to enroll 51 patients … |